Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy.

RA Reisfeld, BM Mueller, R Handgretinger, AliceLin-Tsing Yu, SD Gillies

研究成果: 期刊稿件 › 文章 › 同行評審

UN SDG

此研究成果有助於以下永續發展目標

@article{ff0ba0bf23984f5c9300e2a5df41696a,

title = "Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy.",

author = "RA Reisfeld and BM Mueller and R Handgretinger and AliceLin-Tsing Yu and SD Gillies",

year = "1994",

language = "American English",

volume = "101",

pages = "201--212",

journal = "Progress in Brain Research",

issn = "0079-6123",

publisher = "Elsevier B.V.",

}